IBJNews

Arcadia reports smaller loss on increased revenue

Back to TopCommentsE-mailPrintBookmark and Share

Arcadia Resources Inc. continued to shed money in its most recent quarter but took a smaller loss than it did in the same period of 2009, the Indianapolis-based health care company said Wednesday.

Arcadia lost $2.3 million, or 1 cent per share, on revenue of $26.2 million in its third fiscal quarter, which ended Dec. 31. That compares to a loss of $3.2 million, or 2 cents per share, on revenue of $25.7 million for the same quarter in 2009.

“These results continue to move us down the path of achieving profitability and becoming cash-flow positive,” said Arcadia President and CEO Marvin R. Richardson in a prepared statement. “We have seen steady improvement in our Services segment profitability, even though underlying market conditions remain challenging.”

In its pharmacy segment, Arcadia reported revenue of $5 million in the latest quarter, marking a 22.6-percent increase for its DailyMed medication-management system over same period in 2009.

Arcadia’s DailyMed service packages doses of prescriptions into individual packets, to make it easier for patients on numerous medications to stick to their regimens.

Quarterly revenue in the services segment was $21.1 million, down slightly from $21.6 million in the same quarter in 2009.

DailyMed currently is offered in WellPoint-affiliated health plans in California, Kansas, South Carolina and Virginia.

Arcadia stock fell 4 cents Wednesday, to 20 cents per share, a decline of 18.2 percent.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT